Get started
Author

Charlotte O’Brien-Gore

Observed names: C Gore, C. Gore, Charlotte Gore, Charlotte O'Brien-Gore, Charlotte O’Brien Gore
ORCID: 0000-0002-4568-1351
Observed ORCID: 0000-0002-4568-1351
OpenAlex ID: A5018930124
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
2021 · Leticia Monin, Adam G Laing, et al. · The Lancet Oncology · 629
PDF
The role of DAB2IP in androgen receptor activation during prostate cancer progression
2013 · K Wu, J Liu, et al. · Oncogene · 51
3D multicellular systems in disease modelling: From organoids to organ-on-chip
2023 · Caoimhe Goldrick, Ina Guri, et al. · Frontiers in Cell and Developmental Biology · 46
PDF
Drivers of Inflammation in Psoriatic Arthritis: the Old and the New
2021 · Charlotte O’Brien-Gore, Elizabeth H. Gray, et al. · Current Rheumatology Reports · 19
Anaesthetic management of a pregnant patient with multiple myeloma
2010 · D.M. Dabrowska, C. Gore, et al. · International Journal of Obstetric Anesthesia · 16
Spurious Hb Mass Increases Following Exercise
2012 · C. Gough, A. Eastwood, et al. · International Journal of Sports Medicine · 15
Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy products
2023 · Charlotte O’Brien Gore, Amy Billman, et al. · Molecular Therapy — Oncolytics · 9
The socioeconomic effect of COVID-19 on pediatric ophthalmologists: data from the first 12 months
2022 · Lance M. Siegel, Brent A. Siegel, et al. · Journal of American Association for Pediatric Ophthalmology and Strabismus · 1
PDF
Works count: 8
Citation count: 786
H-index: 7
I10-index: 6
Year
Topic
Type